In this week’s Monday Market Highlights, Dealer Will McVeagh looks into the US MOVE index and two-year bond yield, both impacted by moves triggered by the collapse of SVB and Signature Bank. He also discusses global investment bank Credit Suisse, and the US February CPI data released last week. In equity news, Will covers Neuren Pharmaceuticals’ phase 3 FDA approval for its drug to treat Rett Syndrome, and bus operator Kelsian’s move into the US market.
Listen to the podcast on your favourite platform:
